Pune, Maharashtra -- (SBWIRE) -- 05/15/2017 -- Market Highlights:

Asthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid. Symptoms include tight chest, wheezing, cough and may be limitation of activity due to difficulty in breathing.

Approximately, 300 million people suffer from asthma in 2015 and the figures are mounting which is blamed on increased pollution and unhealthy lifestyles. This has bloated the market to around USD 18.9 billion as of 2015 which is expected to reach USD 28.3 billion as of 2022, resulting in a CAGR of 5.94%. The factors favoring the growth of the market are growing awareness of the benefits of modern drug therapy, strong pipeline of Anti-Asthma Drugs Market with some novel molecules, growth in patients due to increasing pollution and great potential of biologics which is anticipated to dominate the future market etc.

Major Key Players:
-GlaxoSmithKline plc.
-Merck & Co., Inc.
-AstraZeneca plc.
-F. Hoffmann-La Roche Ltd
-Teva Pharmaceutical Industries
-Novartis International AG
-Boehringer Ingelheim
-Sunovion Pharmaceuticals Inc

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2353

Regional Analysis:
Globally North America is the largest market for anti-asthma drugs. Europe is the second-largest market for anti-asthma drugs. The developing region especially Asia Pacific is accounting for major newer cases due to greater screening and better health care facilities distribution. However the developing regions market particularly Asia Pacific will be the fastest growing and will be the key to the future.

Segmentation:
Global anti-asthma drugs market has been segmented on the basis of type (allergic (extrinsic) and non-allergic (intrinsic)), by trigger (child-onset, adult-onset, exercise-induced, cough-induced, occupational, nocturnal, steroid-resistant), by therapy (reliever treatment and maintenance treatment), by drug class (Bronchodilators (beta agonists, anti-cholinergics, xanthines), leukotriene antagonists, mast cell stabilizers, corticosteroids, monoclonal antibody) and by route of administration (oral, inhaled, intravenous, subcutaneous).

Access Report Details @ https://www.marketresearchfuture.com/reports/anti-asthma-drugs-market-2353

Intended Audience:
-Global anti-asthma drugs manufacturers
-Global anti-asthma drugs suppliers
-Research and development Laboratories
-Market Research and Consulting Service Providers

Table of Contents
1Introduction
1.1Definition
1.2Scope Of Study
1.3Research Objective
1.4Assumptions & Limitations
1.5Market Structure
2Research Methodology
2.1Research Process
2.2Primary Research
2.3Secondary Research

List of Tables
Table 1 Global Anti-Asthma Drugs Market, 2013-2022 (Usd Million)
Table 2 Global Anti-Asthma Drugs Market, By Types, 2013-2022 (Usd Million)

List of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.